Hua Medicine (02552) reported that its total authorized share capital remained at USD 2,000,000, with no changes during the month of October 2025. The company’s total issued shares also stayed unchanged at 1,056,605,016.
According to the Post-IPO Share Option Scheme, the number of outstanding share options decreased slightly, from 59,569,669 to 59,289,669, reflecting 280,000 lapsed options. No other share warrant, convertible, or agreement-related movements were disclosed for October 2025.